Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2334

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic ; volume:14 ; number:4 ; day:29 ; month:5 ; year:2014 ; pages:1 ; date:5.2014
BMC infectious diseases ; 14, Heft 4 (29.5.2014), 1, 5.2014

Creator: Huik, Kristi

Contributor: Rajasaar, Heli
Avi, Radko
Pauskar, Merit
Ustina, Valentina
Kink, Kersti
Novikova, Lilia
Maimets, Matti
Zilmer, Kai
Lutsar, Irja
SpringerLink (Online service)

DOI: 10.1186/1471-2334-14-S4-O18

URN: urn:nbn:de:1111-2016030324065

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Huik, Kristi
Rajasaar, Heli
Avi, Radko
Pauskar, Merit
Ustina, Valentina
Kink, Kersti
Novikova, Lilia
Maimets, Matti
Zilmer, Kai
Lutsar, Irja
SpringerLink (Online service)

Other Objects (12)

HIV-HCV Co-infection Among Blood Donors

No strategy to meet the HCV epidemic

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients

HCV co-infection in HIV positive population in British Columbia, Canada

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients

HCV co-infection is related to acute ischemic severity and outcome

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection

The “hidden” epidemic: a snapshot of Moroccan intravenous drug users

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination

Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype

Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study

Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review

HIV-HCV Co-infection Among Blood Donors

No strategy to meet the HCV epidemic

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients

HCV co-infection in HIV positive population in British Columbia, Canada

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients

HCV co-infection is related to acute ischemic severity and outcome

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection

The “hidden” epidemic: a snapshot of Moroccan intravenous drug users

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination

Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype

Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study

Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review

HIV-HCV Co-infection Among Blood Donors

No strategy to meet the HCV epidemic

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients

HCV co-infection in HIV positive population in British Columbia, Canada

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients

HCV co-infection is related to acute ischemic severity and outcome

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection

The “hidden” epidemic: a snapshot of Moroccan intravenous drug users

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination

Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype

Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study

Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

HIV-HCV Co-infection Among Blood Donors

No strategy to meet the HCV epidemic

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients

HCV co-infection in HIV positive population in British Columbia, Canada

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients

HCV co-infection is related to acute ischemic severity and outcome

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection

The “hidden” epidemic: a snapshot of Moroccan intravenous drug users

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination

Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype

Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study

Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review

HIV-HCV Co-infection Among Blood Donors

No strategy to meet the HCV epidemic

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients

HCV co-infection in HIV positive population in British Columbia, Canada

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients

HCV co-infection is related to acute ischemic severity and outcome

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection

The “hidden” epidemic: a snapshot of Moroccan intravenous drug users

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination

Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype

Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study

Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review

HIV-HCV Co-infection Among Blood Donors

No strategy to meet the HCV epidemic

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients

HCV co-infection in HIV positive population in British Columbia, Canada

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients

HCV co-infection is related to acute ischemic severity and outcome

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection

The “hidden” epidemic: a snapshot of Moroccan intravenous drug users

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination

Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype

Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study

Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review

Related objects

Reset password